Study details
Enrolling now
Ethnic Differences in Mechanisms of Action of Dupilumab
University of Michigan
NCT IDNCT05268107ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
30
Study length
about 4.4 years
Ages
18+
Locations
1 site in MI
What this study is about
This trial is testing how different ethnic groups respond to the drug dupilumab for atopic dermatitis. The goal is to understand if there are differences in how inflammation works in people with AD based on their ethnicity.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Dupilumab
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
dupilumab
Body systems
Dermatology